HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs

Substance Use and Misuse

Volumn 43, Issue 3-4, 2008, Pages 521-534

  Shannon, Kate ^a,c,d   Rusch, Melanie ^a,c   Morgan, Robert ^b   Oleson, Megan ^a,b   Kerr, Thomas ^a,c   Tyndall, Mark W ^a,c  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b VANCOUVER AREA NETWORK OF DRUG USERS   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

Crack cocaine smoking; Crack use kits; Drug consumption rooms; Dual use; Gender; Harm reduction; HCV; HIV

Indexed keywords

ADULT; ARTICLE; COCAINE DEPENDENCE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER IDENTITY; HARM REDUCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INJECTION; MAJOR CLINICAL STUDY; MALE; MONEY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLICE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CRACK COCAINE; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK-TAKING; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 41349109168     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080701772355     Document Type: Article

References (39)

1. Booth, R. E. (1995). Gender differences in high-risk sex behaviours among heterosexual drug injectors and crack smokers. The American Journal of Drug and Alcohol Abuse 21(4):419-432.
2. Booth, R. E., Kwiatkowski, C. F., Chitwood, D. D. (2000). Sex related HIV risk behaviours: Differential risks among injection drug users, crack smokers and injection drug users who smoke crack. Drug and Alcohol Dependence 58:219-226.
3. Booth, R. E., Watters, J. K., Chitwood, D. D. (1993). HIV risk-related sex behaviours among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health 83(8):1144-1148.
4. Chaisson, M., Stoneburner, R., Hildebrandt, D., Ewing, W., Telzak, E., Jaffe, H. (1991). Heterosexual transmission of HIV-1 associated with the use of smokeable freebase cocaine (crack). AIDS 5(9):1121-1126.
5. Chirgwin, K., DeHovitz, J. A. (1991). HIV infection, genital ulcer disease, and crack cocaine use among patients attending a clinic for sexually transmitted diseases. American Journal of Public Health 81(12):1576-1579.
6. Csete, J., Cohen, J. (2003). Abusing the user: Police misconduct, harm reduction and HIV/AIDS in Vancouver [Electronic version]. Human Rights Watch 15(2B):1-28.
7. De Irala, J., Bigelow, C., McCusker, J., Hindin, R., Zheng, L. (1996). Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. American Journal of Epidemiology 143(7):725-732.
8. Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., et al. (1994). Intersecting epidemics - Crack cocaine use and HIV infection among inner-city young adults. Multicenter crack cocaine and HIV infection study team. New England Journal of Medicine 331(21):1422-1427.
9. Evans, J., Hahn, J., Page-Shafer, Lum, P., Stein, E., Davidson, P., et al. (2003). Gender differences in sexual and injection risk behaviour among active young injection drug users in San Fransisco (the UFO study). Journal of Urban Health 80:1137-1146.
10. Faruque, S., Edlin, B. R., McCoy, C. B., Word, C. O., Larsen, S. A., Schmid, D. S., Von Bargen, J. C., Serrano, Y. (1996). Crack cocaine smoking and oral sores in three inner-city neighbourhoods. Journal of Acquired Immune Deficiciency Syndromes & Human Retrovirology 13(1):87-92.
11. Hagan, H., Des Jarlais, D. C. (2000). HIV and HCV infection among injecting drug users. Mount Sinai Journal of Medicine 67(5-6):423-428.
12. Haydon, E., Fischer, B. (2005). Crack use as a public health problem in Canada: Call for an evaluation of "safer crack use kits." Canadian Journal of Public Health 96(3):185-188.
13. Hendrich, D. (2004). European report on drug consumption rooms. European Monitoring Centre for Drugs and Drug Addiction.
14. Hoffman, J., Klein, H., Eber, M., Crosby, H. (2000). Frequency and intensity of crack use as predictors of women's involvement in HIV-related sexual risk behaviors. Drug & Alcohol Dependence 58(3):227-236.
15. Inciardi, J. (1995). Crack, crack house sex, and HIV risk. Archives of Sexual Behaviour 24(3):249-269.
16. Jones, D., Irwin, K. L., Inciardi, J. A., Bowser, B., Schilling, R. F., Word, C. O., et al. (1998). The highrisk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. Sexually Transmitted Diseases 25(4):187-193.
17. Kerr, T., Tyndall, M.W., Li, K., Montaner, J. S., Wood, E. (2005). Syringe sharing and safer injection facility use. The Lancet 366(9482):316-318.
18. McCoy, C. B., Lai, S., Metsch, L. R., Messiah, S. E., Zhao, W. (2004). Injection drug use and crack cocaine smoking: Independent and dual risk behaviors for HIV infection. Annals of Epidemiology 14(8):535-542.
19. McMahon, J., Tortu, S. (2003). A potential hidden source of hepatitis C infection among noninjection drug users. Journal of Psychoactive Drugs 35:455-460.
20. Millson, P., Myers, T., Rankin, J., McLaughlin, B., Major, C., Mindell, W., et al. (1995). Prevalence of human immunodeficiency virus and associated risk behaviour in injection drug users in Toronto. Canadian Journal of Public Health 86(3):176-180.
21. O'Connell, J., Kerr, T., Li, K., Tyndall, M. W., Hogg, R. S., Montaner, J. S., et al. (2005). Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes 40(1):83-88.
22. Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., et al. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS 8(7):437-445.
23. Perlman, D. C., Henman, A. R., Kochems, L., Paone, D., Salomon, N., Des Jarlais, D. C. (1999). Doing a shotgun: A drug use practice and its relationship to sexual behaviors and infection risk. Social Science & Medicine 48(10):1441-1448.
24. Porter, J., Bonilla, L. (1993). Crack users' cracked lips: An additional HIV risk factor. American Journal of Public Health 83(10):1490-1491.
25. Riehman, K., Kral, A. H., Anderson, R., Flynn, N., Bluthenthal, R. N. (2004). Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. Journal of Urban Health 81(2):249-259.
26. Shannon, K., Ishida, T., Morgan, R., Bear, A., Oleson, M., Kerr, T., et al. (2006). Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduction Journal 3(1):1-8.
27. Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Ksobiech, K., Hackl, K. L. (2003). Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women. AIDS and Behavior 7(4):383-393.
28. Spittal, P. M., Craib, K. J., Wood, E., Laliberte, N., Li, K., Tyndall, M. W., et al. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 166(7):894-899.
29. Surratt, H. L., Inciardi, J. A., Weaver, J. C., FalÚ, V. M. (2005). Emerging linkages between substance abuse and HIV infection in St. Croix, US Virgin Islands. AIDS Care 17(Suppl. 1):26-35.
30. Tortu, S., McMahon, J. M., Pouget, E. R., Hamid, R. (2004). Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use & Misuse 39(2):211-224.
31. Tortu, S., Neaigus, A., McMahon, J., Hagen, D. (2001). Hepatitis C among noninjection drug users: A report. Substance Use & Misuse 36(4):523-534.
32. Tyndall, M. W., Spittal, P. M., Laliberte, N., Li, K., O'Shaughnessy, M. V., Schechter, M. T. (2002). Intensive injection cocaine use as a primary risk factor of HIV seroconversion among polydrug users in Vancouver. AIDS 17(6):887-893.
33. Ward, H., Pallecaros, A., Green, A., Day, S. (2000). Health issues associated with increasing use of "crack" cocaine among female sex workers in London. Sexually Transmitted Infections 76:292-293.
34. Wolf, J., Linseen, L., Graaf, I. D. (2003). Drug consumption facilities in The Netherlands. Journal of Drug Issues, 649-661.
35. Wood, E., Kerr, T., Stoltz, J., Qui, Z., Zhang, R., Montaner, J. S., et al. (2005). Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. Public Health 119(12):1111-1115.
36. Wood, E., Kerr, T., Small, W., Li, K., Marsh, D., Montaner, J. S., et al. (2004a). Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal 171:731-734.
37. Wood, E., Spittal, P., Small, W., Kerr, T., Tyndall, M., Hogg, R. S., et al. (2004b). Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ 170(10):1551-1556.
38. Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Anis, A. H., Hogg, R. S., et al. (2003). Impact of supply-side policies for control of illicit drugs in the face of the aids and overdose epidemics: Investigation of a massive heroin seizure. CMAJ 168(2):165-169.
39. Word, C. O., Bowser, B. (1997). Background to crack cocaine addiction and HIV high-risk behavior: The next epidemic. American Journal of Drug and Alcohol Abuse 23(1):67-77.